SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SMX (Security Matters) Plc is a holding company, which engages in the provision of authentication solutions. It offers brand protection, authentication, and track and trace technology. The company was founded by Haggai Alon on July 1, 2022 and is headquartered in Dublin, Ireland.

SMX (Security Matters) Plc

SMX (Security Matters) PLC

SMX is trending after securing a $250 million capital commitment that extends its operational runway to 2028, fueling community debate between those anticipating a major short squeeze as the company shifts to revenue generation, and others worried about continued dilution and fundamental value.

Churchill Capital Corp. X is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Michael Klein on January 4, 2024 and is headquartered in New York, NY.

Churchill Capital Corp X - Ordinary Shares - Class A

Churchill Capital Corp X 

Churchill Capital Corp X (CCCX) is a major talking point as Infleqtion, its quantum technology merger target, recently secured a NASA space mission role and a significant U.S. Department of Energy contract, leading many to believe it's severely undervalued compared to other quantum stocks ahead of its anticipated merger and ticker change to INFQ.

Fiserv, Inc. engages in the provision of financial services technology. It operates through the Merchant and Financial segments. The Merchant segment offers commerce-enabling products and services including merchant acquiring and digital commerce and mobile payment services, and security and fraud protection, stored-value, and pay-by-bank solutions to companies of all sizes. The Financial segment provides products and services such as processing of customer loan and deposit accounts, digital payments, and card transactions to financial institutions and corporate and public sector clients. The company was founded by Leslie M. Muma and George D. Dalton on July 31, 1984 and is headquartered in Milwaukee, WI.

Fiserv, Inc.

Following its recent earnings report, Fiserv is seeing divided community discussion around its perceived deep value and turnaround potential under new leadership, while concerns persist over its debt, shrinking margins, and the broader fintech sector's challenges.

Spotify Technology SA engages in the provision of digital music services. It operates through the Premium and Ad-Supported segments. The Premium segment provides subscribers with online and offline streaming access of music and podcasts on computers, tablets, and mobile devices. The Ad-Supported segment offers users with limited on-demand online access of music and unlimited online access of podcasts on computers, tablets, and mobile and smart devices. The company was founded by Daniel Ek and Martin Lorentzon on December 27, 2006 and is headquartered in Luxembourg.

Spotify Technology S.A.

Spotify is rallying after a strong earnings report showcased impressive user and subscriber growth alongside improved profitability and optimistic guidance, prompting analyst upgrades and expectations for higher price targets. The community is actively discussing these strategic gains, even as debate continues around recent subscription price increases and competition in the streaming sector.

Jumia Technologies AG engages in the provision of logistic services. It operates a pan-African e-commerce platform. It operates through the following geographical segments: West Africa, North Africa, East and South Africa, Europe, United Arab Emirates, and Others. The company was founded by Jeremy Hodara, Sacha Poignonnec, Peter Allerstorfer, Manuel Koser, Tunde Kehinde, and Raphael Afaedor in 2012 and is headquartered in Berlin, Germany.

Jumia Technologies Ag - ADR

Jumia Technologies trends after an earnings report revealed strong revenue and GMV growth, significant cash burn reduction, and a clear path to profitability without needing a capital raise, yet the stock's initial dip has puzzled many long-term investors who view it as the "Amazon of Africa" for an underserved market.

Oscar Health, Inc. is a health insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

Oscar Health is generating buzz following its latest earnings report, where a substantial 2026 guidance predicting profitability and record membership growth is fueling a bullish narrative. This optimism directly contrasts with a quarterly financial miss that has skeptics questioning the sustainability of its aggressive forward outlook amidst broader healthcare sector uncertainties.

Evommune, Inc. is a clinical-stage biotechnology company. It engages in the development of medicines for inflammatory diseases. The company was founded by Luis C. Pena, Eugene Andrew Bauer, and Hans Hofland in 2020 and is headquartered in Palo Alto, CA.

Evommune Inc.

Evommune Inc

Evommune is seeing a surge in attention after announcing positive Phase 2a trial results for its atopic dermatitis drug EVO301, sparking a battle between bullish traders anticipating a short squeeze and a skeptical community betting against the rally amid claims of overvaluation.

Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit. The company was founded in 1990 and is headquartered in San Francisco, CA.

Nektar Therapeutics

Nektar Therapeutics is trending after reporting strong 52-week maintenance data for its atopic dermatitis drug, rezpegaldesleukin, demonstrating durable efficacy comparable to or exceeding competitors like Dupixent. The community is buzzing about the drug's potential, with many anticipating higher price targets, a significant short squeeze, and the possibility of a big pharma buyout.

Datadog, Inc. engages in the development of a monitoring and analytics platform for developers, information technology operations teams and business users. Its platform integrates and automates infrastructure monitoring, application performance monitoring and log management to provide real-time observability of its customers' entire technology stack. The company was founded by Olivier Pomel and Alexis Lê-Quôc on June 4, 2010 and is headquartered in New York, NY.

Datadog Inc - Ordinary Shares - Class A

Datadog Inc

Datadog is trending after reporting strong Q4 earnings that initially sent the stock higher, driven by significant client additions and an upbeat outlook. However, these gains were quickly erased as concerns over increased competition in the observability sector, including recent acquisitions by rivals, are actively weighing on community sentiment.

The Coca-Cola Co. engages in the manufacturing and marketing of non-alcoholic beverages. It operates through the following segments: Europe, Middle East and Africa, Latin America, North America, Asia Pacific, Global Ventures, and Bottling Investments. The company was founded by Asa Griggs Candler on May 8, 1886 and is headquartered in Atlanta, GA.

Coca-Cola Co

Coca-Cola is trending as investors digest its latest earnings, which featured an EPS beat but a revenue miss, sparking community discussion on its valuation as a defensive play even with a continued dividend increase and strategic focus on healthier beverages.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Verrica Pharmaceuticals (NASDAQ:VRCA) Downgraded to Hold Rating by Wall Street Zen

Wall Street Zen cut shares of Verrica Pharmaceuticals from a "buy" rating to a "hold" rating in a report on Saturday...

Verrica Pharmaceuticals (VRCA) Upgraded to Strong Buy: Here's Why

Verrica Pharmaceuticals (VRCA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

New Strong Buy Stocks for February 2nd

LUV, VRCA, CVLT, FINW and SDVKY have been added to the Zacks Rank #1 (Strong Buy) List on February 2, 2026.

Sovran Advisors LLC Trims Holdings in Verrica Pharmaceuticals Inc. $VRCA

Sovran Advisors LLC trimmed its holdings in Verrica Pharmaceuticals Inc. (NASDAQ:VRCA - Free Report) by 90.2% in the 3rd quarter, according to the company in its most recent filing with the...

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Short Interest Update

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA - Get Free Report) saw a significant drop in short interest in December. As of December 31st, there was short interest totaling 292,263 shares, a drop of...

Verrica Pharmaceuticals (NASDAQ:VRCA) Upgraded to "Buy" at Wall Street Zen

Wall Street Zen raised shares of Verrica Pharmaceuticals from a "hold" rating to a "buy" rating in a research note on Saturday...

How Much Upside is Left in Verrica Pharmaceuticals (VRCA)? Wall Street Analysts Think 97.11%

The mean of analysts' price targets for Verrica Pharmaceuticals (VRCA) points to a 97.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Short Interest in Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Decreases By 26.2%

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA - Get Free Report) was the recipient of a significant decrease in short interest in December. As of December 15th, there was short interest totaling 380,561...

Armistice Capital LLC Increases Stock Holdings in Verrica Pharmaceuticals Inc. $VRCA

Armistice Capital LLC boosted its stake in Verrica Pharmaceuticals Inc. (NASDAQ:VRCA - Free Report) by 3.7% in the second quarter, according to its most recent filing with the Securities and Exchange...

Verrica Pharmaceuticals (NASDAQ:VRCA) CEO Jayson Rieger Purchases 94,311 Shares

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA - Get Free Report) CEO Jayson Rieger acquired 94,311 shares of the business's stock in a transaction that occurred on Tuesday, November 25th. The shares were...

Verrica Pharmaceuticals, Inc. is a dermatology therapeutics company, which engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its products include Pipeline VP-102, Pipeline VP-103, and Pipeline VP-315. The company was founded by Matthew Davidson on July 3, 2013 and is headquartered in West Chester, PA.

Verrica Pharmaceuticals Inc

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $SHOP earnings on Wednesday?

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.73	--	--	N/A
Q3 '25	-$0.38	-$0.03	92.06%	BEAT
Q2 '25	-$0.90	$0.02	102.22%	BEAT
Q1 '25	-$0.13	-$1.00	-692.60%	MISSED
Q4 '24	-$0.25	-$0.24	4.00%	BEAT

VRCA
Verrica Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest VRCA News

VRCAVerrica Pharmaceuticals Inc